Assembly Biosciences, Inc. (ASMB) Misses Q1 EPS by $1.39

Assembly Biosciences, Inc. (NASDAQ: ASMB) reported Q1 EPS of ($1.66), $1.39 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $5.79 million.

For earnings history and earnings-related data on Assembly Biosciences, Inc. (ASMB) click here.

You May Also Be Interested In

• JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
• KB Home (KBH) PT Raised to $56 at Truist Securities
• Benchmark Reiterates Hold Rating on Old Dominion Freight Line (ODFL) as 'Quality Largely Priced in'